247 related articles for article (PubMed ID: 27977936)
1. Potent inhibition of human organic cation transporter 2 (hOCT2) by β-carboline alkaloids.
Wagner DJ; Duan H; Chapron A; Lee RW; Wang J
Xenobiotica; 2017 Dec; 47(12):1112-1120. PubMed ID: 27977936
[TBL] [Abstract][Full Text] [Related]
2. Expression and pharmacological profile of the human organic cation transporters hOCT1, hOCT2 and hOCT3.
Hayer-Zillgen M; Brüss M; Bönisch H
Br J Pharmacol; 2002 Jul; 136(6):829-36. PubMed ID: 12110607
[TBL] [Abstract][Full Text] [Related]
3. Interaction of antidepressant and antipsychotic drugs with the human organic cation transporters hOCT1, hOCT2 and hOCT3.
Haenisch B; Drescher E; Thiemer L; Xin H; Giros B; Gautron S; Bönisch H
Naunyn Schmiedebergs Arch Pharmacol; 2012 Oct; 385(10):1017-23. PubMed ID: 22806583
[TBL] [Abstract][Full Text] [Related]
4. Differential substrate and inhibitory activities of ranitidine and famotidine toward human organic cation transporter 1 (hOCT1; SLC22A1), hOCT2 (SLC22A2), and hOCT3 (SLC22A3).
Bourdet DL; Pritchard JB; Thakker DR
J Pharmacol Exp Ther; 2005 Dec; 315(3):1288-97. PubMed ID: 16141367
[TBL] [Abstract][Full Text] [Related]
5. The mitochondrial fluorescent dye rhodamine 123 is a high-affinity substrate for organic cation transporters (OCTs) 1 and 2.
Jouan E; Le Vee M; Denizot C; Da Violante G; Fardel O
Fundam Clin Pharmacol; 2014 Feb; 28(1):65-77. PubMed ID: 22913740
[TBL] [Abstract][Full Text] [Related]
6. Interaction of six protoberberine alkaloids with human organic cation transporters 1, 2 and 3.
Li L; Sun S; Weng Y; Song F; Zhou S; Bai M; Zhou H; Zeng S; Jiang H
Xenobiotica; 2016; 46(2):175-83. PubMed ID: 26134304
[TBL] [Abstract][Full Text] [Related]
7. Transcellular transport of organic cations in double-transfected MDCK cells expressing human organic cation transporters hOCT1/hMATE1 and hOCT2/hMATE1.
Sato T; Masuda S; Yonezawa A; Tanihara Y; Katsura T; Inui K
Biochem Pharmacol; 2008 Oct; 76(7):894-903. PubMed ID: 18674516
[TBL] [Abstract][Full Text] [Related]
8. The interaction of alkaloids in Coptis chinensis Franch -Tetradium ruticarpum (A. Juss.) T.G. Hartley with hOCT1 and hOCT2.
Zhang S; Liu X; Li L; Zhang Y; Wang X; Li Y; Huang Y; Pan G
J Ethnopharmacol; 2022 Sep; 295():115395. PubMed ID: 35597409
[TBL] [Abstract][Full Text] [Related]
9. Impact of Substrate-Dependent Inhibition on Renal Organic Cation Transporters hOCT2 and hMATE1/2-K-Mediated Drug Transport and Intracellular Accumulation.
Yin J; Duan H; Wang J
J Pharmacol Exp Ther; 2016 Dec; 359(3):401-410. PubMed ID: 27758931
[TBL] [Abstract][Full Text] [Related]
10. Human organic cation transporters 1 (SLC22A1), 2 (SLC22A2), and 3 (SLC22A3) as disposition pathways for fluoroquinolone antimicrobials.
Mulgaonkar A; Venitz J; Gründemann D; Sweet DH
Antimicrob Agents Chemother; 2013 Jun; 57(6):2705-11. PubMed ID: 23545524
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of human organic cation transporters by the alkaloids matrine and oxymatrine.
Pan X; Wang L; Gründemann D; Sweet DH
Fitoterapia; 2014 Jan; 92():206-10. PubMed ID: 24291757
[TBL] [Abstract][Full Text] [Related]
12. Transport of dicationic drugs pentamidine and furamidine by human organic cation transporters.
Ming X; Ju W; Wu H; Tidwell RR; Hall JE; Thakker DR
Drug Metab Dispos; 2009 Feb; 37(2):424-30. PubMed ID: 18971316
[TBL] [Abstract][Full Text] [Related]
13. Characterization of
López Quiñones AJ; Wagner DJ; Wang J
Mol Pharmacol; 2020 Aug; 98(2):109-119. PubMed ID: 32487736
[TBL] [Abstract][Full Text] [Related]
14. Transport of guanidine compounds by human organic cation transporters, hOCT1 and hOCT2.
Kimura N; Masuda S; Katsura T; Inui K
Biochem Pharmacol; 2009 Apr; 77(8):1429-36. PubMed ID: 19426682
[TBL] [Abstract][Full Text] [Related]
15. Interaction Profiles of Central Nervous System Active Drugs at Human Organic Cation Transporters 1-3 and Human Plasma Membrane Monoamine Transporter.
Angenoorth TJF; Stankovic S; Niello M; Holy M; Brandt SD; Sitte HH; Maier J
Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884800
[TBL] [Abstract][Full Text] [Related]
16. Substrate- and cell contact-dependent inhibitor affinity of human organic cation transporter 2: studies with two classical organic cation substrates and the novel substrate cd2+.
Thévenod F; Ciarimboli G; Leistner M; Wolff NA; Lee WK; Schatz I; Keller T; Al-Monajjed R; Gorboulev V; Koepsell H
Mol Pharm; 2013 Aug; 10(8):3045-56. PubMed ID: 23763587
[TBL] [Abstract][Full Text] [Related]
17. Drug specificity and intestinal membrane localization of human organic cation transporters (OCT).
Müller J; Lips KS; Metzner L; Neubert RH; Koepsell H; Brandsch M
Biochem Pharmacol; 2005 Dec; 70(12):1851-60. PubMed ID: 16263091
[TBL] [Abstract][Full Text] [Related]
18. Atenolol Renal Secretion Is Mediated by Human Organic Cation Transporter 2 and Multidrug and Toxin Extrusion Proteins.
Yin J; Duan H; Shirasaka Y; Prasad B; Wang J
Drug Metab Dispos; 2015 Dec; 43(12):1872-81. PubMed ID: 26374172
[TBL] [Abstract][Full Text] [Related]
19. Organic cation transporters OCT1, 2, and 3 mediate high-affinity transport of the mutagenic vital dye ethidium in the kidney proximal tubule.
Lee WK; Reichold M; Edemir B; Ciarimboli G; Warth R; Koepsell H; Thévenod F
Am J Physiol Renal Physiol; 2009 Jun; 296(6):F1504-13. PubMed ID: 19357179
[TBL] [Abstract][Full Text] [Related]
20. Creatinine transport by basolateral organic cation transporter hOCT2 in the human kidney.
Urakami Y; Kimura N; Okuda M; Inui K
Pharm Res; 2004 Jun; 21(6):976-81. PubMed ID: 15212162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
